GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Total Operating Expense

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Total Operating Expense : $11.97 Mil (TTM As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Total Operating Expense?

CERo Therapeutics Holdings's Total Operating Expense for the six months ended in Dec. 2022 was $11.97 Mil. CERo Therapeutics Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 was $11.97 Mil.


CERo Therapeutics Holdings Total Operating Expense Historical Data

The historical data trend for CERo Therapeutics Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Total Operating Expense Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Total Operating Expense
11.62 11.97

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Total Operating Expense 11.62 11.97

CERo Therapeutics Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 was $11.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CERo Therapeutics Holdings Total Operating Expense Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines